Benjamin Roberts, DO
Otolaryngology/Facial Plastic Surgery · Murrieta, CANPI 1740526748
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 37 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Optinose US, Inc. at 25.2% of the total. That places this record below the midpoint for otolaryngology/facial plastic surgery clinicians in CA, where the typical reported total is $1,073.
Across 37 payments — averaging $23.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$216
- Inspire Medical Systems, Inc.$178
- Aerin Medical Inc.$118
- Acclarent, Inc$95
- Sanofi$83
- Regeneron Healthcare Solutions, Inc.$71
- plus $96 from 4 others
What the payments were for
- Food & beverage$856100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 9 | $216 |
| Inspire Medical Systems, Inc. | 7 | $178 |
| Aerin Medical Inc. | 5 | $118 |
| Acclarent, Inc | 5 | $95 |
| Sanofi | 3 | $83 |
| Regeneron Healthcare Solutions, Inc. | 3 | $71 |
| Medtronic | 2 | $41 |
| Intersect ENT, Inc. | 1 | $21 |
| Johnson & Johnson | 1 | $18 |
| GSK | 1 | $16 |
How this compares
$856 in reported general payments places this provider in the 40th percentile of 102 otolaryngology/facial plastic surgery providers in California.
See all otolaryngology/facial plastic surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 628 | $8,744 |
| Azelastine Hcl | 231 | $5,062 |
| Ipratropium Bromide | 88 | $2,559 |
| Ofloxacin | 24 | $244 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $145 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 28 | $94 |
| Mupirocin | 18 | $80 |
| Omeprazole | 16 | $74 |
| Amoxicillin | 14 | $22 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology/facial plastic surgery in Murrieta
- Todd RobertsMurrieta$3K
- Sarmela SunderLancaster$85K
- Vasu DiviStanford$51K
- Jen ChowArcadia$26K
- Ryan CasserlyMonterey$23K
- Ritvik MehtaCarlsbad$13K
- Alexis FurzeNewport Beach$12K
- Jahangir SharifiLos Angeles$12K
- Henry NguyenRancho Cucamonga$11K
- Paul NassifBeverly Hills$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.